A New Tool in the Obesity Management Toolbox
Consult QD
JANUARY 15, 2024
These repurposed diabetes medications, including semaglutide and tirzepatide, have surged in popularity since the first was approved in 2021 for long-term weight management. Growing understanding about the chronic nature of obesity indicates long-term management is necessary for patients to maintain their weight loss.
Let's personalize your content